병원내 감염 관리 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Hospital Acquired Infection Control Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,055,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,304,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,999,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 이번에 세계의 병원내 감염 관리 시장에 관한 종합적 리포트를 발표했습니다. 시장 촉진요인·동향·기회·과제를 포함한 중요한 시장 역학을 철저히 평가하고, 시장 구조에 관한 상세 인사이트를 제공하고 있습니다.

주요 인사이트

• 병원내 감염 관리 시장 규모(2024년) : 71억 3,000만 달러
• 예측 시장 금액(2033년) : 101억 달러
• 세계 시장 성장률(CAGR, 2024-2033년) : 3.9%

병원내 감염 관리 시장 - 리포트 범위 :

병원내 감염(HAI)이란 헬스케어 환경에서 환자가 내과적 또는 외과적 질환의 치료를 받고 있는 동안에 감염하는 것입니다. HAI 대책 시장에는 요로감염증, 수술부위감염 증, 폐렴, 혈류감염증 등의 감염증 예방, 진단, 치료를 목적으로 한 제품과 서비스가 포함됩니다. 이 시장의 주요 제품에는 멸균 장비, 소독제, 감시 시스템, 진단 장비 등이 있습니다. HAI 대책 시장은 병원, 진료소, 장기 케어 시설, 진단 연구소를 대상으로 하고 있습니다.

시장 성장 촉진요인 :

세계의 병원내 감염 관리 시장은 HAI의 만연, 헬스케어 지출의 증가, 환자의 안전성 향상을 목적으로 한 엄격한 규제 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 살균 및 소독 기술의 발전과 혁신적인 진단 툴의 개발은 감염 관리의 효율성을 높이고 있습니다. 또한 의료 전문가와 환자들 사이에서 감염 예방에 대한 인식과 교육이 높아지면서 시장 성장을 가속하고 있습니다.

시장 성장 억제요인 :

유망한 성장 전망에도 불구하고, 감염관리 시장은 첨단 감염관리 제품 및 장비의 높은 비용, 규제 준수, 의료진에 대한 지속적인 교육 필요성 등 여러 가지 도전과제에 직면해 있습니다. 감염 제어 제품의 제조 및 사용을 규정하는 엄격한 규제는 제조업체와 의료 서비스 프로바이더에게 컴플라이언스 부담을 부과하고 시장 진입 장벽과 운영 비용에 영향을 미칩니다. 또한 특정 감염관리 시술에 대한 제한적인 보험급여 범위는 특히 의료 예산이 제한된 신흥 국가에서는 시장 침투에 어려움을 겪고 있습니다.

시장 기회 :

HAI 대책 시장은 기술 혁신, 인구 동향, 진화하는 의료 서비스 제공 모델로 인해 큰 성장 기회를 맞이하고 있습니다. 실시간 감염 모니터링 시스템 및 전자 의료 기록과 같은 디지털 건강 기술의 통합은 감염 관리 프로그램의 효과를 높일 수 있습니다. 또한 저침습 수술의 채택 확대와 외래 환자 치료 환경의 확대는 시장 참여자들에게 새로운 길을 열어주고 있습니다. 전략적 파트너십, R&D 투자, 비용 효율적이고 사용하기 쉬운 감염관리 솔루션의 도입은 새로운 기회를 활용하고 시장 리더십을 유지하는 데 필수적입니다.

이 보고서에서 다룬 주요 질문

• 세계 병원내 감염 관리 시장의 성장을 가속하는 주요 요인은?
• 다양한 헬스케어 환경에서 채택을 촉진하는 제품 및 용도는 무엇인가?
• 기술의 발전은 HAI 제어 시장 경쟁 구도를 어떻게 변화시키고 있는가?
• HAI 제어 시장에 기여하는 주요 기업은 어디이며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 HAI 제어 시장의 새로운 트렌드와 미래 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한
• 포함 사항·제외 사항

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 주요 성공요인

• 제품의 채택/사용 상황 분석
• 주요 마케팅·프로모션 전략 : 제조업체별
• 규제 상황
• 환불 시나리오
• 품질 감시 프로그램
• PESTEL 분석
• Porter의 산업 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• 2024년 시장 시나리오
• COVID-19와 영향 분석
  • 제품별
  • 최종사용자별
  • 지역별

제7장 세계의 병원내 감염 관리 시장의 수요 분석

• 과거 시장 분석 : 2019-2023년
• 현재 및 향후 시장 예측, 2024-2033년
  • 전년대비 성장 동향 분석

제8장 세계의 병원내 감염 관리 시장 - 가격 분석

• 지역별 가격 분석 : 제품별
• 가격의 내역
  • 제조업체 레벨 가격결정
  • 유통업체 레벨 가격결정
• 세계 평균 가격 분석 벤치마크
• 가격결정 전제조건

제9장 세계의 병원내 감염 관리 시장의 수요 분석

• 과거 시장 금액 분석 : 2019-2023년
• 현재 및 향후 시장 금액 예측, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대액의 기회 분석

제10장 세계의 병원내 감염 관리 시장 분석 : 제품별

• 서론/주요 조사 결과
• 과거 시장 규모와 수량 분석 : 제품별, 2019-2023년
• 현재 및 향후 시장 규모와 수량 분석과 예측 : 제품별, 2024-2033년
  • 가열살균 장비
  • 저온 살균 장비
  • 방사선 멸균 장비
  • 소독 장비
• 시장의 매력 분석 : 제품별

제11장 세계의 병원내 감염 관리 시장 분석 : 최종사용자별

• 서론/주요 조사 결과
• 과거 시장 규모 분석 : 최종사용자별 : 2019-2023년
• 현재 및 향후 시장 규모의 분석과 예측 : 최종사용자별, 2024-2033년
  • 병원
  • 외래 수술 센터
  • 의료기관
  • 진단 검사실
  • 클리닉
• 시장의 매력 분석 : 최종사용자별

제12장 세계의 병원내 감염 관리 시장 분석 : 지역별

• 서론
• 과거 시장 규모와 수량 분석 : 지역별, 2019-2023년
• 현재 및 향후 시장 규모와 수량 분석과 예측 : 지역별, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제13장 북미의 병원내 감염 관리 시장 분석

제14장 라틴아메리카의 병원내 감염 관리 시장 분석

제15장 유럽의 병원내 감염 관리 시장 분석

제16장 남아시아의 병원내 감염 관리 시장 분석

제17장 동아시아의 병원내 감염 관리 시장 분석

제18장 오세아니아의 병원내 감염 관리 시장 분석

제19장 중동 및 아프리카(MEA) 병원내 감염 관리 시장 분석

제20장 시장 구조 분석

• 시장 분석 : 기업 계층별
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제21장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁의 상세 정보
  • Olympus Corporation
  • Medivators Inc.(Cantel Medical Corp.)
  • Getinge Group
  • STERIS Plc.
  • Belimed AG(Metall Zug)
  • Steelco SPA
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck &Co.
  • Advanced Sterilization Products Services Inc.(Johnson &Johnson)
  • Abbott Laboratories
  • Bayer AG
  • Alere Inc.
  • The 3M Company
  • Cepheid Inc.
  • UVision360 Inc.

제22장 사용되는 전제 조건과 두자어

제23장 조사 방법

KSA

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for hospital acquired infection control. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Hospital Acquired Infection Control Market Size (2024E): USD 7.13 Billion
• Projected Market Value (2033F): USD 10.1 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 3.9%

Hospital Acquired Infection Control Market - Report Scope:

Hospital acquired infections (HAIs) are infections that patients acquire while receiving treatment for medical or surgical conditions in healthcare settings. The market for HAI control includes products and services designed to prevent, diagnose, and treat infections such as urinary tract infections, surgical site infections, pneumonia, and bloodstream infections. Key products in this market include sterilization equipment, disinfectants, surveillance systems, and diagnostic devices. The HAI control market caters to hospitals, clinics, long-term care facilities, and diagnostic laboratories.

Market Growth Drivers:

The global hospital acquired infection control market is propelled by several key factors, including the rising prevalence of HAIs, increasing healthcare expenditures, and stringent regulations aimed at improving patient safety. Advances in sterilization and disinfection technologies, along with the development of innovative diagnostic tools, enhance the efficacy of infection control measures. Additionally, growing awareness and education about infection prevention among healthcare professionals and patients further drive market growth.

Market Restraints:

Despite promising growth prospects, the HAI control market faces challenges related to the high costs of advanced infection control products and equipment, regulatory compliance, and the need for continuous training of healthcare staff. The stringent regulations governing the manufacturing and use of infection control products impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for certain infection control procedures poses challenges for market penetration, particularly in emerging economies with constrained healthcare budgets.

Market Opportunities:

The HAI control market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as real-time infection surveillance systems and electronic health records, enhances the effectiveness of infection control programs. Additionally, the increasing adoption of minimally invasive surgical procedures and the expansion of outpatient care settings create new avenues for market players. Strategic partnerships, investment in research and development, and the introduction of cost-effective, user-friendly infection control solutions are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the hospital acquired infection control market globally?
• Which products and applications are driving adoption across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the HAI control market?
• Who are the key players contributing to the HAI control market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global HAI control market?

Competitive Intelligence and Business Strategy:

Leading players in the global hospital acquired infection control market, including 3M Company, Johnson & Johnson, and Becton, Dickinson and Company, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced infection control solutions, such as automated sterilization systems, advanced disinfectants, and rapid diagnostic tests, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving infection control landscape.

Key Companies Profiled:

• Olympus Corporation
• Medivators Inc. (Cantel Medical Corp.)
• Getinge Group
• STERIS Plc.
• Belimed AG (Metall Zug)
• Steelco S.P.A
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Merck & Co.
• Advanced Sterilization Products Services Inc. (Johnson & Johnson)
• Abbott Laboratories
• Bayer AG
• Alere Inc.
• The 3M Company
• Cepheid Inc
• UVision360 Inc.

Key Segments of the Hospital Acquired Infection Control Market

By Product :

• Heat Sterilization Equipment
• Low-Temperature Sterilization Equipment
• Radiation Sterilization Equipment
• Disinfection Equipment

By End User :

• Hospitals
• Ambulatory Surgical Centres
• Medical Institutions
• Diagnostic Laboratories
• Clinics

By Region :

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Key Marketing & Promotion Strategies, By Manufacturers
• 4.3. Regulatory Landscape
• 4.4. Reimbursement Scenario.
• 4.5. Quality Monitoring Programs
• 4.6. PESTEL Analysis
• 4.7. Porter's Analysis.

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Industry Outlook
  • 5.1.3. Hospital Acquired Infection Market Overview
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Rising Focus on Personal Hygiene
  • 5.2.2. Increasing Prevalence of Infectious Diseases
  • 5.2.3. New Product Launch Activities
  • 5.2.4. Technological Advancements
  • 5.2.5. Increasing Minimally Invasive Procedures
  • 5.2.6. Susceptible Patients and Surgical Procedures
  • 5.2.7. Co-Existing Infections
  • 5.2.8. Increased Funding and Support from the Government
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. 2024 Market Scenario
• 6.2. COVID-19 and Impact Analysis
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Region

7. Global Hospital Acquired Infection Control Market Demand (in Volume) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market (Volume) Analysis, 2019-2023
• 7.2. Current and Future Market (Volume) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Hospital Acquired Infection Control Market - Pricing Analysis

• 8.1. Regional Pricing Analysis, By Product
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Hospital Acquired Infection Control Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2033
  • 10.3.1. Heat Sterilization Equipment
    • 10.3.1.1. Moist Heat Sterilization Equipment
    • 10.3.1.2. Dry Heat Sterilization Equipment
  • 10.3.2. Low Temperature Sterilization Equipment
  • 10.3.3. Radiation Sterilization Equipment
  • 10.3.4. Disinfection Equipment
    • 10.3.4.1. Disinfector
      • 10.3.4.1.1. Washer Disinfector
      • 10.3.4.1.2. Flusher Disinfector
    • 10.3.4.2. Endoscopic Reprocessor Systems
      • 10.3.4.2.1. Single Basin Endoscopic Reprocessor Systems
      • 10.3.4.2.2. Dual Basin Endoscopic Reprocessor Systems
    • 10.3.4.3. Disinfectants
• 10.4. Market Attractiveness Analysis, By Product

11. Global Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2033
  • 11.3.1. Hospitals
  • 11.3.2. Ambulatory Surgical Centers
  • 11.3.3. Medical Institutions
  • 11.3.4. Diagnostic Laboratories
  • 11.3.5. Clinics
• 11.4. Market Attractiveness Analysis, By End User

12. Global Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Region, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. South Asia
  • 12.3.5. East Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East and Africa
• 12.4. Market Attractiveness Analysis, By Region

13. North America Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Product
  • 13.3.3. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By End User
• 13.5. Key Market Participants - Intensity Mapping
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Key Market Trends
• 13.8. Country-Level Analysis & Forecast
  • 13.8.1. U.S. Hospital Acquired Infection Control Market
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By End User
  • 13.8.2. Canada Hospital Acquired Infection Control Market
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By End User

14. Latin America Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Mexico
    • 14.3.1.2. Brazil
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Product
  • 14.3.3. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By End User
• 14.5. Key Market Participants - Intensity Mapping
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Market Trends
• 14.8. Country-Level Analysis & Forecast
  • 14.8.1. Mexico Hospital Acquired Infection Control Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By End User
  • 14.8.2. Brazil Surgical Imaging Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By End User
  • 14.8.3. Argentina Hospital Acquired Infection Control Market
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By End User

15. Europe Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. U.K.
    • 15.3.1.2. Germany
    • 15.3.1.3. Italy
    • 15.3.1.4. France
    • 15.3.1.5. Spain
    • 15.3.1.6. Russia
    • 15.3.1.7. BENELUX
    • 15.3.1.8. Rest of Europe
  • 15.3.2. By Product
  • 15.3.3. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By End User
• 15.5. Key Market Participants - Intensity Mapping
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Market Trends
• 15.8. Country-Level Analysis & Forecast
  • 15.8.1. U.K. Hospital Acquired Infection Control Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By End User
  • 15.8.2. Germany Hospital Acquired Infection Control Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By End User
  • 15.8.3. Italy Hospital Acquired Infection Control Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By End User
  • 15.8.4. France Hospital Acquired Infection Control Market
    • 15.8.4.1. Introduction
    • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.4.2.1. By Product
      • 15.8.4.2.2. By End User
  • 15.8.5. Spain Hospital Acquired Infection Control Market
    • 15.8.5.1. Introduction
    • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.5.2.1. By Product
      • 15.8.5.2.2. By End User
  • 15.8.6. Russia Hospital Acquired Infection Control Market
    • 15.8.6.1. Introduction
    • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.6.2.1. By Product
      • 15.8.6.2.2. By End User
  • 15.8.7. BENULUX Hospital Acquired Infection Control Market
    • 15.8.7.1. Introduction
    • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.7.2.1. By Product
      • 15.8.7.2.2. By End User

16. South Asia Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Indonesia
    • 16.3.1.3. Malaysia
    • 16.3.1.4. Thailand
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Product
  • 16.3.3. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By End User
• 16.5. Key Market Participants - Intensity Mapping
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Market Trends
• 16.8. Country-Level Analysis & Forecast
  • 16.8.1. India Hospital Acquired Infection Control Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By End User
  • 16.8.2. Indonesia Hospital Acquired Infection Control Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By End User
  • 16.8.3. Malaysia Hospital Acquired Infection Control Market
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By End User
  • 16.8.4. Thailand Hospital Acquired Infection Control Market
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By End User

17. East Asia Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product
  • 17.3.3. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By End User
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Market Trends
• 17.8. Country-Level Analysis & Forecast
  • 17.8.1. China Hospital Acquired Infection Control Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By End User
  • 17.8.2. Japan Hospital Acquired Infection Control Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By End User
  • 17.8.3. South Korea Hospital Acquired Infection Control Market
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By End User

18. Oceania Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Product
  • 18.3.3. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By End User
• 18.5. Key Market Participants - Intensity Mapping
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Market Trends
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. Australia Hospital Acquired Infection Control Market
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By End User
  • 18.8.2. New Zealand Hospital Acquired Infection Control Market
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By End User

19. Middle East and Africa (MEA) Hospital Acquired Infection Control Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkey
    • 19.3.1.3. South Africa
    • 19.3.1.4. North Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Product
  • 19.3.3. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By End User
• 19.5. Key Market Participants - Intensity Mapping
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Key Market Trends
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. GCC Countries Hospital Acquired Infection Control Market
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By End User
  • 19.8.2. Turkey Hospital Acquired Infection Control Market
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By End User
  • 19.8.3. South Africa Hospital Acquired Infection Control Market
    • 19.8.3.1. Introduction
    • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.3.2.1. By Product
      • 19.8.3.2.2. By End User
  • 19.8.4. North Africa Hospital Acquired Infection Control Market
    • 19.8.4.1. Introduction
    • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.4.2.1. By Product
      • 19.8.4.2.2. By End User

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Presence Analysis
  • 20.3.1. Regional footprint of Players
  • 20.3.2. Product foot print by Players
  • 20.3.3. Channel Foot Print by Players

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Benchmarking
• 21.3. Competition Deep Dive
  • 21.3.1. Olympus Corporation
    • 21.3.1.1. Company Overview
    • 21.3.1.2. Product Portfolio
    • 21.3.1.3. Sales Footprint
    • 21.3.1.4. Key Financials
    • 21.3.1.5. SWOT Analysis
    • 21.3.1.6. Key Developments
    • 21.3.1.7. Strategy Overview
      • 21.3.1.7.1. Marketing Strategy
      • 21.3.1.7.2. Product Strategy
      • 21.3.1.7.3. Channel Strategy
  • 21.3.2. Medivators Inc. (Cantel Medical Corp.)
    • 21.3.2.1. Company Overview
    • 21.3.2.2. Product Portfolio
    • 21.3.2.3. Sales Footprint
    • 21.3.2.4. Key Financials
    • 21.3.2.5. SWOT Analysis
    • 21.3.2.6. Key Developments
    • 21.3.2.7. Strategy Overview
      • 21.3.2.7.1. Marketing Strategy
      • 21.3.2.7.2. Product Strategy
      • 21.3.2.7.3. Channel Strategy
  • 21.3.3. Getinge Group
    • 21.3.3.1. Company Overview
    • 21.3.3.2. Product Portfolio
    • 21.3.3.3. Sales Footprint
    • 21.3.3.4. Key Financials
    • 21.3.3.5. SWOT Analysis
    • 21.3.3.6. Key Developments
    • 21.3.3.7. Strategy Overview
      • 21.3.3.7.1. Marketing Strategy
      • 21.3.3.7.2. Product Strategy
      • 21.3.3.7.3. Channel Strategy
  • 21.3.4. STERIS Plc.
    • 21.3.4.1. Company Overview
    • 21.3.4.2. Product Portfolio
    • 21.3.4.3. Sales Footprint
    • 21.3.4.4. Key Financials
    • 21.3.4.5. SWOT Analysis
    • 21.3.4.6. Key Developments
    • 21.3.4.7. Strategy Overview
      • 21.3.4.7.1. Marketing Strategy
      • 21.3.4.7.2. Product Strategy
      • 21.3.4.7.3. Channel Strategy
  • 21.3.5. Belimed AG (Metall Zug)
    • 21.3.5.1. Company Overview
    • 21.3.5.2. Product Portfolio
    • 21.3.5.3. Sales Footprint
    • 21.3.5.4. Key Financials
    • 21.3.5.5. SWOT Analysis
    • 21.3.5.6. Key Developments
    • 21.3.5.7. Strategy Overview
      • 21.3.5.7.1. Marketing Strategy
      • 21.3.5.7.2. Product Strategy
      • 21.3.5.7.3. Channel Strategy
  • 21.3.6. Steelco S.P.A
    • 21.3.6.1. Company Overview
    • 21.3.6.2. Product Portfolio
    • 21.3.6.3. Sales Footprint
    • 21.3.6.4. Key Financials
    • 21.3.6.5. SWOT Analysis
    • 21.3.6.6. Key Developments
    • 21.3.6.7. Strategy Overview
      • 21.3.6.7.1. Marketing Strategy
      • 21.3.6.7.2. Product Strategy
      • 21.3.6.7.3. Channel Strategy
  • 21.3.7. Pfizer Inc.
    • 21.3.7.1. Company Overview
    • 21.3.7.2. Product Portfolio
    • 21.3.7.3. Sales Footprint
    • 21.3.7.4. Key Financials
    • 21.3.7.5. SWOT Analysis
    • 21.3.7.6. Key Developments
    • 21.3.7.7. Strategy Overview
      • 21.3.7.7.1. Marketing Strategy
      • 21.3.7.7.2. Product Strategy
      • 21.3.7.7.3. Channel Strategy
  • 21.3.8. F. Hoffmann-La Roche Ltd
    • 21.3.8.1. Company Overview
    • 21.3.8.2. Product Portfolio
    • 21.3.8.3. Sales Footprint
    • 21.3.8.4. Key Financials
    • 21.3.8.5. SWOT Analysis
    • 21.3.8.6. Key Developments
    • 21.3.8.7. Strategy Overview
      • 21.3.8.7.1. Marketing Strategy
      • 21.3.8.7.2. Product Strategy
      • 21.3.8.7.3. Channel Strategy
  • 21.3.9. Merck & Co.
    • 21.3.9.1. Company Overview
    • 21.3.9.2. Product Portfolio
    • 21.3.9.3. Sales Footprint
    • 21.3.9.4. Key Financials
    • 21.3.9.5. SWOT Analysis
    • 21.3.9.6. Key Developments
    • 21.3.9.7. Strategy Overview
      • 21.3.9.7.1. Marketing Strategy
      • 21.3.9.7.2. Product Strategy
      • 21.3.9.7.3. Channel Strategy
  • 21.3.10. Advanced Sterilization Products Services Inc. (Johnson & Johnson)
    • 21.3.10.1. Company Overview
    • 21.3.10.2. Product Portfolio
    • 21.3.10.3. Sales Footprint
    • 21.3.10.4. Key Financials
    • 21.3.10.5. SWOT Analysis
    • 21.3.10.6. Key Developments
    • 21.3.10.7. Strategy Overview
      • 21.3.10.7.1. Marketing Strategy
      • 21.3.10.7.2. Product Strategy
      • 21.3.10.7.3. Channel Strategy
  • 21.3.11. Abbott Laboratories
    • 21.3.11.1. Company Overview
    • 21.3.11.2. Product Portfolio
    • 21.3.11.3. Sales Footprint
    • 21.3.11.4. Key Financials
    • 21.3.11.5. SWOT Analysis
    • 21.3.11.6. Key Developments
    • 21.3.11.7. Strategy Overview
      • 21.3.11.7.1. Marketing Strategy
      • 21.3.11.7.2. Product Strategy
      • 21.3.11.7.3. Channel Strategy
  • 21.3.12. Bayer AG
    • 21.3.12.1. Company Overview
    • 21.3.12.2. Product Portfolio
    • 21.3.12.3. Sales Footprint
    • 21.3.12.4. Key Financials
    • 21.3.12.5. SWOT Analysis
    • 21.3.12.6. Key Developments
    • 21.3.12.7. Strategy Overview
      • 21.3.12.7.1. Marketing Strategy
      • 21.3.12.7.2. Product Strategy
      • 21.3.12.7.3. Channel Strategy
  • 21.3.13. Alere Inc.
    • 21.3.13.1. Company Overview
    • 21.3.13.2. Product Portfolio
    • 21.3.13.3. Sales Footprint
    • 21.3.13.4. Key Financials
    • 21.3.13.5. SWOT Analysis
    • 21.3.13.6. Key Developments
    • 21.3.13.7. Strategy Overview
      • 21.3.13.7.1. Marketing Strategy
      • 21.3.13.7.2. Product Strategy
      • 21.3.13.7.3. Channel Strategy
  • 21.3.14. The 3M Company
    • 21.3.14.1. Company Overview
    • 21.3.14.2. Product Portfolio
    • 21.3.14.3. Sales Footprint
    • 21.3.14.4. Key Financials
    • 21.3.14.5. SWOT Analysis
    • 21.3.14.6. Key Developments
    • 21.3.14.7. Strategy Overview
      • 21.3.14.7.1. Marketing Strategy
      • 21.3.14.7.2. Product Strategy
      • 21.3.14.7.3. Channel Strategy
  • 21.3.15. Cepheid Inc.
    • 21.3.15.1. Company Overview
    • 21.3.15.2. Product Portfolio
    • 21.3.15.3. Sales Footprint
    • 21.3.15.4. Key Financials
    • 21.3.15.5. SWOT Analysis
    • 21.3.15.6. Key Developments
    • 21.3.15.7. Strategy Overview
      • 21.3.15.7.1. Marketing Strategy
      • 21.3.15.7.2. Product Strategy
      • 21.3.15.7.3. Channel Strategy
  • 21.3.16. UVision360 Inc.
    • 21.3.16.1. Company Overview
    • 21.3.16.2. Product Portfolio
    • 21.3.16.3. Sales Footprint
    • 21.3.16.4. Key Financials
    • 21.3.16.5. SWOT Analysis
    • 21.3.16.6. Key Developments
    • 21.3.16.7. Strategy Overview
      • 21.3.16.7.1. Marketing Strategy
      • 21.3.16.7.2. Product Strategy
      • 21.3.16.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료